Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XTZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $8,339
Award facts
- Contract value 100% obligated
- $8,339.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on September 22, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is for the supply of Xtandi 80 mg tablets (60-count units) valued at $8,339.18. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of September 23, 2025. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the issuance of delivery orders for comprehensive pharmaceutical products supporting Department of Defense healthcare facilities worldwide. No set-aside designation was applied to this particular delivery order.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards predominantly to the Defense Logistics Agency covering an extensive range of medical products including prescription medications, biologics, and medical consumables. The company's experience delivering specialty pharmaceutical items such as oncology treatments, auto-injectors, and contraceptive devices demonstrates its capability to support military health system requirements across the country. The funding originates from the Medical Supply Chain component within the Department of Defense.
Quick answers
Who was awarded contract SPE2DX25F6XTZ?
SPE2DX25F6XTZ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 22, 2025.
How much is contract SPE2DX25F6XTZ worth?
The government has obligated $8,339 on SPE2DX25F6XTZ.
Is contract SPE2DX25F6XTZ an order under another contract?
Yes. SPE2DX25F6XTZ is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTZ competed?
The extent of competition for SPE2DX25F6XTZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award